Correlation Between Virpax Pharmaceuticals and Emmaus Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Emmaus Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Emmaus Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Emmaus Life Sciences, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Emmaus Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Emmaus Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Emmaus Life.

Diversification Opportunities for Virpax Pharmaceuticals and Emmaus Life

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Virpax and Emmaus is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Emmaus Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emmaus Life Sciences and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Emmaus Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emmaus Life Sciences has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Emmaus Life go up and down completely randomly.

Pair Corralation between Virpax Pharmaceuticals and Emmaus Life

If you would invest  31.00  in Virpax Pharmaceuticals on October 11, 2024 and sell it today you would earn a total of  6.00  from holding Virpax Pharmaceuticals or generate 19.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy5.0%
ValuesDaily Returns

Virpax Pharmaceuticals  vs.  Emmaus Life Sciences

 Performance 
       Timeline  
Virpax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virpax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Virpax Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Emmaus Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Emmaus Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Emmaus Life is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Virpax Pharmaceuticals and Emmaus Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virpax Pharmaceuticals and Emmaus Life

The main advantage of trading using opposite Virpax Pharmaceuticals and Emmaus Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Emmaus Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will offset losses from the drop in Emmaus Life's long position.
The idea behind Virpax Pharmaceuticals and Emmaus Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities